Benefits
EU traditional herbal use for mild symptoms of mental stress
The European Medicines Agency lists linden flower tea, liquid extract and tincture as a traditional herbal medicine for the relief of mild symptoms of mental stress in adults and adolescents. This status rests on long-standing use, and the agency's own review found no controlled clinical trials of linden for stress or mood.
Traditional hot tea taken to promote sweating in the cold season
Linden tea has long been drunk very hot as a sweat-promoting drink, and the EU monograph recognizes it for relief of common cold symptoms based on that tradition. The only controlled human study the agency described was an open study of inhaled linden vapor with no statistical analysis, so this use is not backed by trials of the tea.
Sleep questionnaire scores with a linden, hawthorn and melatonin blend
In an uncontrolled 30-day study of 41 adults with sleep complaints, a nightly tablet of linden extract with hawthorn, vitamin B1 and 1 mg melatonin was followed by lower sleep and insomnia questionnaire scores. There was no placebo group and the blend contained melatonin, so the result cannot be credited to linden.
Calming and sleep-promoting effects in mouse and nerve cell studies
In mice, linden flower water extracts had sedative effects, a flower fraction given by injection had anxiety-reducing effects, and a linden extract increased non-REM (NREM) sleep and reduced brief awakenings. These are animal and cell findings and have not been confirmed in human trials.
Flower polyphenols that dampen immune cell signals in lab tests
In laboratory work, procyanidins isolated from Tilia cordata flowers lowered reactive oxygen species and the inflammatory signal IL-8 from human immune cells, and linden extract fermented with human gut bacteria lowered TNF release. These are test tube results, not effects measured in people who drank the tea.
Mechanism of action
GABA-A and benzodiazepine-site activity (lab data)
In mouse brain cells, linden bud extracts opened the same chloride channel as the calming messenger GABA, and the effect was largely blocked by GABA-A and benzodiazepine site blockers. An earlier study found flower fractions that bind the benzodiazepine site. Whether tea reaches the brain in active amounts is unknown.
Flavonoids, procyanidins and mucilage in the flowers
The flowers carry flavonoid glycosides, mainly tiliroside, along with procyanidins, phenolic acids and about 3% mucilage polysaccharides built from sugars such as arabinose, galactose and rhamnose. These are the compounds studied in the lab work above; the EMA found no human pharmacology data on any of them.
Breakdown by gut bacteria
When linden flower extract was incubated with stool samples from healthy donors, gut bacteria turned its constituents into about 20 metabolites and the bacterial mix shifted toward short-chain fatty acid producers. This suggests the compounds people absorb after drinking linden may differ from those in the cup.
Weak acetylcholinesterase inhibition by flower alkaloids (lab data)
Newly identified piperidine and dihydropyrrole alkaloids from lime flowers weakly inhibited acetylcholinesterase and strengthened acetylcholine-driven airway muscle contraction in mouse tissue, while a whole flower extract had no effect. Their relevance to drinking the tea is unknown.
Clinical trials
Controlled human absorption study measuring incorporation of radiolabeled iron into red blood cells after a bread meal taken with water or with test beverages, including lime flower (Tilia cordata) tea (Hurrell et al. 1999, Br J Nutr)
Adult human volunteers; each beverage was compared with a water control meal.
Lime flower tea reduced nonheme iron absorption from the meal by 52% compared with water. All the polyphenol-containing drinks inhibited iron absorption, depending on their polyphenol content, from 47% for chamomile to 79 to 94% for black tea. This is a nutrition and safety finding, not a benefit.
Open, uncontrolled pilot study of a nightly tablet containing Tilia tomentosa extract (150 mg), hawthorn extract (150 mg), vitamin B1 and 1 mg melatonin for 30 days, with an optional further 30 days; product supplied by the maker (De Simone et al. 2023, Med Sci (Basel))
41 adults (mean age 45.3) with sleep disturbance (mean PSQI 8.2); 11 continued for a second month.
PSQI fell 22.4%, ISI 19.6% and DASS-21 total distress 19.5% from baseline after 30 days. There was no placebo group, and the blend included melatonin, so neither expectation effects nor the other ingredients can be ruled out.
Open controlled study summarized by the European Medicines Agency from a WHO monograph: inhalation of vapor from linden flower in hot water for 10 minutes versus vapor from colored water; inhaled, not drunk (European Medicines Agency HMPC 2012, Assessment report)
30 patients with uncomplicated catarrhal disease, 15 per group.
All patients reported some subjective relief, with further improvement described in the linden group. No statistical analysis was done, and the agency concluded an objective assessment is not possible. The agency described no controlled trial of oral linden tea and called for rigorous randomized controlled trials.
Randomized, triple-masked, placebo-controlled parallel trial registered in 2023 of a concentrated Tilia tomentosa bud glycerin macerate (a gemmotherapy product), 1 drop per 10 kg body weight at bedtime for 15 days (Fondazione Policlinico Universitario Agostino Gemelli IRCCS 2023, ClinicalTrials.gov NCT06061666)
Estimated 80 women with sleep problems during hormonal therapy after breast cancer surgery.
No results have been posted or published; the registry status is unknown, last listed as recruiting. Until results appear, it adds no evidence either way.